Search Results - "CONWAY, Charles M"

Refine Results
  1. 1

    Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine by Lipton, Richard B, Croop, Robert, Stock, Elyse G, Stock, David A, Morris, Beth A, Frost, Marianne, Dubowchik, Gene M, Conway, Charles M, Coric, Vladimir, Goadsby, Peter J

    Published in The New England journal of medicine (11-07-2019)
    “…Treatment with the oral calcitonin gene–related peptide receptor antagonist rimegepant resulted in freedom from migraine pain 2 hours after the dose in 20% of…”
    Get full text
    Journal Article
  2. 2

    Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy by Mullin, Kathleen, Kudrow, David, Croop, Robert, Lovegren, Meghan, Conway, Charles M., Coric, Vladimir, Lipton, Richard B.

    Published in Neurology (19-05-2020)
    “…OBJECTIVETo provide the first clinical report that 2 calcitonin gene-related peptide (CGRP) therapies, a small molecule CGRP receptor antagonist and an…”
    Get full text
    Journal Article
  3. 3

    Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine by Berman, Gary, Croop, Robert, Kudrow, David, Halverson, Philip, Lovegren, Meghan, Thiry, Alexandra C., Conway, Charles M., Coric, Vladimir, Lipton, Richard B.

    Published in Headache (01-09-2020)
    “…Objective Evaluate the safety and tolerability of oral rimegepant when used for acute treatment concomitantly with a monoclonal antibody (mAb) targeting the…”
    Get full text
    Journal Article
  4. 4

    Inhibition Mediated by Glycinergic and GABAergic Receptors on Excitatory Neurons in Mouse Superficial Dorsal Horn Is Location-Specific but Modified by Inflammation by Takazawa, Tomonori, Choudhury, Papiya, Tong, Chi-Kun, Conway, Charles M, Scherrer, Grégory, Flood, Pamela D, Mukai, Jun, MacDermott, Amy B

    Published in The Journal of neuroscience (01-03-2017)
    “…The superficial dorsal horn is the synaptic termination site for many peripheral sensory fibers of the somatosensory system. A wide range of sensory modalities…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial by Croop, Robert, Lipton, Richard B, Kudrow, David, Stock, David A, Kamen, Lisa, Conway, Charles M, Stock, Elyse G, Coric, Vladimir, Goadsby, Peter J

    Published in The Lancet (British edition) (02-01-2021)
    “…Rimegepant is a calcitonin gene-related peptide receptor antagonist that has shown efficacy and safety in the acute treatment of migraine. We aimed to compare…”
    Get full text
    Journal Article
  8. 8

    Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial by Croop, Robert, Goadsby, Peter J, Stock, David A, Conway, Charles M, Forshaw, Micaela, Stock, Elyse G, Coric, Vladimir, Lipton, Richard B

    Published in The Lancet (British edition) (31-08-2019)
    “…Rimegepant, a small molecule calcitonin gene-related peptide receptor antagonist, has shown efficacy in the acute treatment of migraine using a standard tablet…”
    Get full text
    Journal Article
  9. 9

    Rimegepant 75 mg for acute treatment of migraine is associated with significant reduction in monthly migraine days: Results from a long-term, open-label study by L’Italien, Gilbert, Popoff, Evan, Johnston, Karissa, McGrath, Donnie, Conway, Charles M, Powell, Lauren, Harris, Linda, Kowalczyk, Nicole, Croop, Robert, Coric, Vladimir

    Published in Cephalalgia reports (01-01-2022)
    “…Background: Rimegepant, a small molecule oral calcitonin gene-related peptide (CGRP) receptor antagonist, is approved for the acute and preventive treatment of…”
    Get full text
    Journal Article
  10. 10

    Blocking the CGRP Pathway for Acute and Preventive Treatment of Migraine: The Evolution of Success by Dubowchik, Gene M, Conway, Charles M, Xin, Alison W

    Published in Journal of medicinal chemistry (09-07-2020)
    “…The pivotal role of calcitonin gene-related peptide (CGRP) in migraine pathophysiology was identified over 30 years ago, but the successful clinical…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Asymmetric Synthesis of Heterocyclic Analogues of a CGRP Receptor Antagonist for Treating Migraine by Luo, Guanglin, Chen, Ling, Conway, Charles M., Kostich, Walter, Macor, John E., Dubowchik, Gene M.

    Published in Organic letters (18-12-2015)
    “…An asymmetric synthesis of novel heterocyclic analogue of the CGRP receptor antagonist rimegepant (BMS-927711, 3) is reported. The cycloheptane ring was…”
    Get full text
    Journal Article
  15. 15

    Asymmetric Synthesis of the Major Metabolite of a Calcitonin Gene-Related Peptide Receptor Antagonist and Mechanism of Epoxide Hydrogenolysis by Luo, Guanglin, Chen, Ling, Conway, Charles M, Kostich, Walter, Johnson, Benjamin M, Ng, Alicia, Macor, John E, Dubowchik, Gene M

    Published in Journal of organic chemistry (07-04-2017)
    “…An asymmetric synthesis of the major metabolite of the calcitonin gene-related peptide recepotor antagonist BMS-846372 is presented. The variously substituted…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Synthesis and SAR of calcitonin gene-related peptide (CGRP) antagonists containing substituted aryl-piperazines and piperidines by Civiello, Rita L., Han, Xiaojun, Beno, Brett R., Chaturvedula, Prasad V., Herbst, John J., Xu, Cen, Conway, Charles M., Macor, John E., Dubowchik, Gene M.

    Published in Bioorganic & medicinal chemistry letters (15-02-2016)
    “…[Display omitted] Calcitonin gene-related peptide (CGRP) is a potent neuropeptide implicated in the pathophysiology of migraine. In the course of seeking CGRP…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Oxime Carbamate—Discovery of a series of novel FAAH inhibitors by Sit, S.Y., Conway, Charles M., Xie, Kai, Bertekap, Robert, Bourin, Clotilde, Burris, Kevin D.

    Published in Bioorganic & medicinal chemistry letters (01-02-2010)
    “…The rationale behind the discovery and the biological evaluations of this novel class of FAAH inhibitors are presented. Both in vitro and in vivo results of…”
    Get full text
    Journal Article
  20. 20

    Calcitonin gene-related peptide (CGRP) receptor antagonists: Pyridine as a replacement for a core amide group by Luo, Guanglin, Chen, Ling, Civiello, Rita, Pin, Sokhom S., Xu, Cen, Kostich, Walter, Kelley, Michelle, Conway, Charles M., Macor, John E., Dubowchik, Gene M.

    Published in Bioorganic & medicinal chemistry letters (15-04-2012)
    “…In our continuing efforts to identify CGRP receptor antagonists that can be dosed orally for the treatment of migraine headache, we have investigated a…”
    Get full text
    Journal Article